Proposed registration of carbimazole in the products Vidalta 15 mg Tablets For Cats and Vidalta 10 mg Tablets For Cats

This consultation closed on 4 July 2013.
Consultation period: 
4 June 2013 to 4 July 2013

The APVMA is considering applications for the registration of Vidalta 15 mg Tablets For Cats and Vidalta 10 mg Tablets For Cats. The products are to be used for the treatment of hyperthyroidism and hyperthyroidism-related clinical signs.

We invite comment from 4 June 2013 to 4 July 2013 on whether the application for registration should be granted.

The APVMA is able to consider comments relating to the legislative grounds for registration, including:

  • occupational health and safety
  • safety and first aid
  • chemistry and manufacture
  • residues
  • environmental fate and toxicity
  • trade
  • efficacy

For more information, see page 18 of Gazette No. 11 - 4 June 2013.

Please send your written submission by email, post or fax to:

Veterinary Medicines Program
Australian Pesticides and Veterinary Medicines Authority
PO Box 6182
Kingston ACT 2604
Email: vetmedicines@apvma.gov.au
Fax: +61 2 6210 4721

For enquiries, please call +61 2 6210 4701.

To protect your privacy, please do not include contact information in your feedback. If you would like a response, please contact us.